Nature Reviews Urology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Inheritance in overactive bladder syndrome

Nicholas Raison, Sachin Malde & Arun SahaiÂ

doi : 10.1038/s41585-022-00667-1

Volume 20 Issue 2, February 2023

Buy The Package and View The Article Online


An app for optimizing UTI screening

Tim Thomas 

doi : 10.1038/s41585-022-00710-1

Buy The Package and View The Article Online


MRI diagnosis and radical prostatectomy outcomes

Tim Thomas 

doi : 10.1038/s41585-022-00711-0

Buy The Package and View The Article Online


SARS-CoV-2 in penile tissue

Tim Thomas 

doi : 10.1038/s41585-022-00700-3

Buy The Package and View The Article Online


Tailored prophylaxis for prostate biopsy

Tim Thomas 

doi : 10.1038/s41585-022-00701-2

Buy The Package and View The Article Online


Tumour-suppressing HIIT serum

Tim Thomas 

doi : 10.1038/s41585-022-00702-1

Buy The Package and View The Article Online


Clinical hypnosis improves LUTS

Tim Thomas 

doi : 10.1038/s41585-022-00703-0

Buy The Package and View The Article Online


A vagina on a chip to model microbiome–host interactions

Louise Stone 

doi : 10.1038/s41585-022-00717-8

Buy The Package and View The Article Online


Modelling AR mutations

Louise Stone 

doi : 10.1038/s41585-022-00718-7

Buy The Package and View The Article Online


Cribriform morphology affects mpMRI imaging

Louise StoneÂ

doi : 10.1038/s41585-022-00719-6

Buy The Package and View The Article Online


Transcription factors in kidney stone disease

Louise Stone 

doi : 10.1038/s41585-022-00720-z

Buy The Package and View The Article Online


Linking the CNS and bladder dysfunction

Louise StoneÂ

doi : 10.1038/s41585-022-00721-y

Buy The Package and View The Article Online


Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?

Maria Chiara MasoneÂ

doi : 10.1038/s41585-023-00724-3

Buy The Package and View The Article Online


A CAF subcluster regulates bladder cancer stemness

Maria Chiara Masone 

doi : 10.1038/s41585-022-00713-y

Buy The Package and View The Article Online


Irreversible electroporation in radio-recurrent prostate cancer

Maria Chiara MasoneÂ

doi : 10.1038/s41585-022-00715-w

Buy The Package and View The Article Online


ARBS heterogeneity in prostate cancer progression

Maria Chiara Masone 

doi : 10.1038/s41585-022-00716-9

Buy The Package and View The Article Online


Molecular characterization of tRCC

Maria Chiara Masone 

doi : 10.1038/s41585-022-00714-x

Buy The Package and View The Article Online


Microfluidics facilitating the use of small extracellular vesicles in innovative approaches to male infertility

Dale M. Goss, Steven A. Vasilescu, Gavin Sacks, David K. Gardner & Majid E. WarkianiÂ

doi : 10.1038/s41585-022-00660-8

Sperm are transcriptionally and translationally quiescent and, therefore, rely on the seminal plasma microenvironment for function, survival and fertilization of the oocyte in the oviduct. The male reproductive system influences sperm function via the binding and fusion of secreted epididymal (epididymosomes) and prostatic (prostasomes) small extracellular vesicles (S-EVs) that facilitate the transfer of proteins, lipids and nucleic acids to sperm. Seminal plasma S-EVs have important roles in sperm maturation, immune and oxidative stress protection, capacitation, fertilization and endometrial implantation and receptivity.

Buy The Package and View The Article Online


PBRM1, SETD2 and BAP1 � the trinity of 3p in clear cell renal cell carcinoma

Joseph Walton, Keith Lawson, Panagiotis Prinos, Antonio Finelli, Cheryl Arrowsmith & Laurie AillesÂ

doi : 10.1038/s41585-022-00659-1

Biallelic inactivation of the tumour suppressor gene Von Hippel–Lindau (VHL) occurs in the vast majority of clear cell renal cell carcinoma (ccRCC) instances, disrupting cellular oxygen-sensing mechanisms to yield a state of persistent pseudo-hypoxia, defined as a continued hypoxic response despite the presence of adequate oxygen levels.

Buy The Package and View The Article Online


Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?

Kenneth Chen, Jonathan O’Brien, Aoife McVey, Pocharapong Jenjitranant, Brian D. Kelly, Veeru Kasivisvanathan, Nathan Lawrentschuk, Declan G. Murphy & Arun A. AzadÂ

doi : 10.1038/s41585-022-00669-z

Androgen deprivation therapy (ADT) alone has been the cornerstone of treatment for patients with newly diagnosed metastatic prostate cancer for the past century. Based on results from landmark trials in the past decade, combination approaches of ADT with chemotherapy or novel hormonal agents have established a new standard of care for these patients.

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?